Heinen Mark Insider Trades

Insider Trading History

Track insider trading activity for Heinen Mark. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Volato Group
Volato Group SOAR
Chief Financial Officer
Holding Value $26.4k 60,919 shares
Last Trade
Mar 27, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.6k 10,000 shares
$0.26
$0.43
Volato Group
Volato Group SOAR
Chief Financial Officer
Holding Value $83.5k 192,963 shares
Last Trade
May 07, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$103k 45,000 shares
$2.29
$0.43
Volato Group
Volato Group SOAR
Chief Financial Officer
Holding Value $3.68k 8,500 shares
Last Trade
Jun 06, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$170k 8,500 shares
$20.00
$0.43
Better Therapeutics- Tradeable Rights - March 2021
Better Therapeutics- Tradeable Rights - March 2021 MCADR
Chief Financial Officer
Holding Value $144k 139,723 shares
Last Trade
Apr 05, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$55.6k 54,000 shares
$1.03
$1.03
Better Therapeutics
Better Therapeutics MCAD
Chief Financial Officer
Holding Value $1.46M 139,723 shares
Last Trade
Apr 05, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$563k 54,000 shares
$10.43
$10.43
Better Therapeutics
Better Therapeutics BTTX
Chief Financial Officer
Holding Value $14 139,723 shares
Last Trade
Apr 05, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$48.6k 54,000 shares
$0.90
$0.00
Mountain Crest Acquisition II - Units (1 Ord Share & 1 Right )
Mountain Crest Acquisition II - Units (1 Ord Share & 1 Right ) MCADU
Chief Financial Officer
Holding Value $1.61M 139,723 shares
Last Trade
Apr 05, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$623k 54,000 shares
$11.54
$11.54
Better Therapeutics- Tradeable Rights - March 2021
Better Therapeutics- Tradeable Rights - March 2021 MCADR
Chief Financial Officer
Holding Value $29.4k 28,550 shares
Last Trade
Mar 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$29.4k 28,550 shares
$1.03
$1.03
Mountain Crest Acquisition II - Units (1 Ord Share & 1 Right )
Mountain Crest Acquisition II - Units (1 Ord Share & 1 Right ) MCADU
Chief Financial Officer
Holding Value $329k 28,550 shares
Last Trade
Mar 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$329k 28,550 shares
$11.54
$11.54
Better Therapeutics
Better Therapeutics BTTX
Chief Financial Officer
Holding Value $2.86 28,550 shares
Last Trade
Mar 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$32.5k 28,550 shares
$1.14
$0.00
Better Therapeutics
Better Therapeutics MCAD
Chief Financial Officer
Holding Value $298k 28,550 shares
Last Trade
Mar 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$298k 28,550 shares
$10.43
$10.43
Better Therapeutics
Better Therapeutics MCAD
See Remarks
Holding Value $894k 85,723 shares
Last Trade
Nov 30, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$164k 15,723 shares
$10.43
$10.43
Better Therapeutics
Better Therapeutics BTTX
See Remarks
Holding Value $8.57 85,723 shares
Last Trade
Nov 30, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$23k 15,723 shares
$1.46
$0.00
Mountain Crest Acquisition II - Units (1 Ord Share & 1 Right )
Mountain Crest Acquisition II - Units (1 Ord Share & 1 Right ) MCADU
See Remarks
Holding Value $989k 85,723 shares
Last Trade
Nov 30, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$181k 15,723 shares
$11.54
$11.54
Better Therapeutics- Tradeable Rights - March 2021
Better Therapeutics- Tradeable Rights - March 2021 MCADR
See Remarks
Holding Value $88.3k 85,723 shares
Last Trade
Nov 30, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$16.2k 15,723 shares
$1.03
$1.03
Better Therapeutics
Better Therapeutics MCAD
See Remarks
Holding Value $730k 70,000 shares
Last Trade
Sep 13, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$273k 26,132 shares
$10.43
$10.43
Better Therapeutics- Tradeable Rights - March 2021
Better Therapeutics- Tradeable Rights - March 2021 MCADR
See Remarks
Holding Value $72.1k 70,000 shares
Last Trade
Sep 13, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$26.9k 26,132 shares
$1.03
$1.03
Mountain Crest Acquisition II - Units (1 Ord Share & 1 Right )
Mountain Crest Acquisition II - Units (1 Ord Share & 1 Right ) MCADU
See Remarks
Holding Value $808k 70,000 shares
Last Trade
Sep 13, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$302k 26,132 shares
$11.54
$11.54
Better Therapeutics
Better Therapeutics BTTX
See Remarks
Holding Value $7 70,000 shares
Last Trade
Sep 13, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$50.7k 26,132 shares
$1.94
$0.00
Better Therapeutics
Better Therapeutics BTTX
See Remarks
Holding Value $4.39 43,868 shares
Last Trade
Sep 12, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$46.3k 23,868 shares
$1.94
$0.00

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up